hepatitis C virus protease inhibitors (Idenix)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehepatitis C virus protease inhibitors (Idenix)
Drug Alias NameHCV protease inhibitors (Idenix)IDX-077IDX-136IDX-316IDX-791
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitors
TargetsHepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIdenix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIdenix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A